Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Glycogen synthase kinase-3 (GSK-3) is associated with various key biological processes, including glucose regulation, apoptosis, protein synthesis, cell signaling, cellular transport, gene transcription, proliferation, and intracellular communication. Accordingly, GSK-3 has been implicated in a wide variety of diseases and specifically targeted for both therapeutic and imaging applications by a large number of academic laboratories and pharmaceutical companies. Here, we review the structure, function, expression levels, and ligand-binding properties of GSK-3 and its connection to various diseases. A selected list of highly potent GSK-3 inhibitors, with IC50 <20 nM for adenosine triphosphate (ATP)-competitive inhibitors and IC50 <5 μM for non-ATP-competitive inhibitors, were analyzed for structure activity relationships. Furthermore, ubiquitous expression of GSK-3 and its possible impact on therapy and imaging are also highlighted. Finally, a rational perspective and possible route to selective and effective GSK-3 inhibitors is discussed.

Original languageEnglish (US)
Pages (from-to)571-593
Number of pages23
JournalTheranostics
Volume6
Issue number4
DOIs
StatePublished - 2016

Fingerprint

Glycogen Synthase Kinase 3
Inhibitory Concentration 50
Therapeutics
Biological Phenomena
Structure-Activity Relationship
Adenosine Triphosphate
Apoptosis
Ligands
Glucose
Pharmaceutical Preparations
Genes
Proteins

Keywords

  • Glycogen synthase kinase-3
  • GSK-3 inhibitors

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging. / Pandey, Mukesh; DeGrado, Timothy R.

In: Theranostics, Vol. 6, No. 4, 2016, p. 571-593.

Research output: Contribution to journalReview article

@article{8784bedb0b924a6c95ef529c4565a7dc,
title = "Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging",
abstract = "Glycogen synthase kinase-3 (GSK-3) is associated with various key biological processes, including glucose regulation, apoptosis, protein synthesis, cell signaling, cellular transport, gene transcription, proliferation, and intracellular communication. Accordingly, GSK-3 has been implicated in a wide variety of diseases and specifically targeted for both therapeutic and imaging applications by a large number of academic laboratories and pharmaceutical companies. Here, we review the structure, function, expression levels, and ligand-binding properties of GSK-3 and its connection to various diseases. A selected list of highly potent GSK-3 inhibitors, with IC50 <20 nM for adenosine triphosphate (ATP)-competitive inhibitors and IC50 <5 μM for non-ATP-competitive inhibitors, were analyzed for structure activity relationships. Furthermore, ubiquitous expression of GSK-3 and its possible impact on therapy and imaging are also highlighted. Finally, a rational perspective and possible route to selective and effective GSK-3 inhibitors is discussed.",
keywords = "Glycogen synthase kinase-3, GSK-3 inhibitors",
author = "Mukesh Pandey and DeGrado, {Timothy R}",
year = "2016",
doi = "10.7150/thno.14334",
language = "English (US)",
volume = "6",
pages = "571--593",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "4",

}

TY - JOUR

T1 - Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging

AU - Pandey, Mukesh

AU - DeGrado, Timothy R

PY - 2016

Y1 - 2016

N2 - Glycogen synthase kinase-3 (GSK-3) is associated with various key biological processes, including glucose regulation, apoptosis, protein synthesis, cell signaling, cellular transport, gene transcription, proliferation, and intracellular communication. Accordingly, GSK-3 has been implicated in a wide variety of diseases and specifically targeted for both therapeutic and imaging applications by a large number of academic laboratories and pharmaceutical companies. Here, we review the structure, function, expression levels, and ligand-binding properties of GSK-3 and its connection to various diseases. A selected list of highly potent GSK-3 inhibitors, with IC50 <20 nM for adenosine triphosphate (ATP)-competitive inhibitors and IC50 <5 μM for non-ATP-competitive inhibitors, were analyzed for structure activity relationships. Furthermore, ubiquitous expression of GSK-3 and its possible impact on therapy and imaging are also highlighted. Finally, a rational perspective and possible route to selective and effective GSK-3 inhibitors is discussed.

AB - Glycogen synthase kinase-3 (GSK-3) is associated with various key biological processes, including glucose regulation, apoptosis, protein synthesis, cell signaling, cellular transport, gene transcription, proliferation, and intracellular communication. Accordingly, GSK-3 has been implicated in a wide variety of diseases and specifically targeted for both therapeutic and imaging applications by a large number of academic laboratories and pharmaceutical companies. Here, we review the structure, function, expression levels, and ligand-binding properties of GSK-3 and its connection to various diseases. A selected list of highly potent GSK-3 inhibitors, with IC50 <20 nM for adenosine triphosphate (ATP)-competitive inhibitors and IC50 <5 μM for non-ATP-competitive inhibitors, were analyzed for structure activity relationships. Furthermore, ubiquitous expression of GSK-3 and its possible impact on therapy and imaging are also highlighted. Finally, a rational perspective and possible route to selective and effective GSK-3 inhibitors is discussed.

KW - Glycogen synthase kinase-3

KW - GSK-3 inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84984843530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984843530&partnerID=8YFLogxK

U2 - 10.7150/thno.14334

DO - 10.7150/thno.14334

M3 - Review article

C2 - 26941849

AN - SCOPUS:84984843530

VL - 6

SP - 571

EP - 593

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 4

ER -